Nephrogenic Systemic Fibrosis (NSF)/Nephrogenic Fibrosing Dermopathy (NFD) is a disorder characterized most visibly by skin lesions and hardened plaques on the skin. Usually, the extremities are most affected. NSF/NFD can also be found in other parts of the body, such as lungs, myocardium and skeletal muscle. The disorder is found in patients with kidney failure. NSF/NFD can be fatal. Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy has been connected to the use of gadolinium-based contrast agents in imaging studies such as MRI. Gadolinium-based contrast agents include Omniscan, Magnevist, ProHance, OptiMARK and MultiHance. Because Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy is similar to other skin conditions, it is a diagnosis of exclusion, using deep tissue biopsy.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.